Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS)
CNY 17.75
(1.89%)
CNY 17.75
(1.89%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 223.68 Million CNY | 27.31% |
| 2022 | 176.48 Million CNY | 46.77% |
| 2021 | 120.24 Million CNY | 8.57% |
| 2020 | 110.75 Million CNY | 12.18% |
| 2019 | 98.72 Million CNY | 27.16% |
| 2018 | 77.63 Million CNY | 2.38% |
| 2017 | 75.83 Million CNY | 3.05% |
| 2016 | 73.59 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 69.77 Million CNY | 1.01% |
| 2024 Q2 | 71.29 Million CNY | 13.13% |
| 2024 Q1 | 63.02 Million CNY | 12.91% |
| 2023 Q3 | 59.31 Million CNY | 6.38% |
| 2023 Q1 | 53.79 Million CNY | 32.27% |
| 2023 FY | 224.67 Million CNY | 27.31% |
| 2023 Q2 | 55.75 Million CNY | 3.65% |
| 2023 Q4 | 55.81 Million CNY | -5.89% |
| 2022 Q3 | 43.31 Million CNY | -2.14% |
| 2022 FY | 176.48 Million CNY | 46.77% |
| 2022 Q4 | 40.66 Million CNY | -6.11% |
| 2022 Q2 | 44.26 Million CNY | -8.22% |
| 2022 Q1 | 48.23 Million CNY | 44.5% |
| 2021 Q4 | 33.37 Million CNY | 26.74% |
| 2021 Q3 | 26.33 Million CNY | -33.64% |
| 2021 Q1 | 20.84 Million CNY | -22.75% |
| 2021 Q2 | 39.68 Million CNY | 90.37% |
| 2021 FY | 120.24 Million CNY | 8.57% |
| 2020 Q2 | 41.08 Million CNY | 130.99% |
| 2020 FY | 110.75 Million CNY | 12.18% |
| 2020 Q4 | 26.98 Million CNY | 8.38% |
| 2020 Q3 | 24.9 Million CNY | -39.39% |
| 2020 Q1 | 17.78 Million CNY | -25.98% |
| 2019 Q3 | 24.02 Million CNY | 8.44% |
| 2019 FY | 98.72 Million CNY | 27.16% |
| 2019 Q4 | 24.02 Million CNY | 0.0% |
| 2019 Q2 | 22.15 Million CNY | 0.0% |
| 2019 Q1 | 22.15 Million CNY | 0.0% |
| 2018 FY | 77.63 Million CNY | 2.38% |
| 2017 FY | 75.83 Million CNY | 3.05% |
| 2016 FY | 73.59 Million CNY | 0.0% |